Skip to main content.

liver cirrhosis

Picture of Rebecca Plevin

How one reporter "fell down a data rabbit hole" while investigating how many Medicaid patients were denied costly hep C drugs, and what she'll do differently next time.

Picture of Rebecca Plevin

Calif.’s revised eligibility rules for new hep C drugs appear to be easing Medicaid patients’ access to the medications, yet the vast majority of Medicaid patients with hep C still aren't getting the costly drugs, state health officials say.

Picture of Admin User

Jinah Choi is an assistant professor in the School of Natural Sciences at UC Merced. Her research focuses on the molecular characterization of hepatitis C virus (HCV) and its interactions with the host. HCV is an important human pathogen. More than 80 percent of HCV infection results in chronic infection that can lead to serious liver diseases, such as liver cirrhosis and hepatocellular carcinoma (i.e. liver cancer). Choi seeks to better understand HCV and its pathogenic mechanisms in order to develop a new and improved anti-HCV therapy. Choi received her Ph.D.

Announcements

The nation's top infectious disease specialist will join us for a conversation with national health reporter Dan Diamond of The Washington Post. We’ll talk about the evolving threat posed by monkeypox, the current state of the COVID pandemic, and broader lessons on how we respond to emerging diseases. Sign-up here!

CONNECT WITH THE COMMUNITY

Follow Us

Facebook


Twitter

CHJ Icon
ReportingHealth